Side-by-side comparison of AI visibility scores, market position, and capabilities
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
CI/CD pipeline automation platform acquired in LBO; configuration-as-code build and test automation competing with GitHub Actions and GitLab CI for enterprise engineering team adoption.
CircleCI is a continuous integration and continuous delivery (CI/CD) platform that automates the software build, test, and deployment pipeline — enabling engineering teams to automatically run tests and deploy code changes whenever developers push new code, dramatically reducing manual release cycles and catching bugs before production. Founded in 2011 by Paul Biggar and Allen Rohner in San Francisco, CircleCI raised approximately $315 million and was acquired by GS Growth (Goldman Sachs) in a leveraged buyout in 2023 after withdrawing a planned IPO.\n\nCircleCI's platform executes CI/CD pipelines using configuration-as-code — developers define their build, test, and deployment steps in a YAML configuration file that lives in the project repository. The platform supports Docker-based builds, test parallelism (splitting test suites across multiple containers to run faster), caching of dependencies (to speed subsequent runs), and integrations with major deployment targets (AWS, GCP, Kubernetes, Heroku). CircleCI's compute is cloud-hosted (CircleCI Cloud) or self-hosted (CircleCI Server for enterprise compliance requirements).\n\nIn 2025, CircleCI competes in the highly competitive CI/CD market against GitHub Actions (which has significantly disrupted the market by offering CI/CD natively within GitHub at no additional cost), GitLab CI, Jenkins, and Buildkite. GitHub Actions' integration with the world's largest code repository platform has created significant pricing and adoption pressure for standalone CI/CD vendors. CircleCI suffered a significant security incident in January 2023 (customer data and secrets breach) that damaged trust, though the company has significantly improved its security posture. The 2025 strategy focuses on CircleCI's performance advantages over GitHub Actions for complex enterprise pipelines, improving developer experience, and growing its large-enterprise self-hosted server product.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.